Companies /Healthcare

LTGO

LTGO Biotechnology
$19.95
▼ $0.87 (−4.17%) today
Markets open · 1:58pm ET
Today · % change

Fundamentals

Market Cap
$1.4B
EPS (TTM)
$-1.85
52-Week Range
$17 – $26
Street Target
$52.25

About LTGO

Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction. The company is headquartered in Thousand Oaks, California.

LTGO Coverage